Kormont

Kluisbergen 11 trials 3 recruiting

11 Registered trials

3 Currently recruiting

Organisation

Kormont

Location

Kluisbergen, Belgium

Identifier

ORG-100046894

Address

Kwaremontplein 45, 9690, Belgium

Departments

-
Cardiology
G.P
GP Practice
Huisartsen Kluisbergen
Kormont
Pneumology
Praktijk Bouvelo - Anzegem (satellite site)
Vercruysse

Clinical trials at this site (11)

Search interface

A study to evaluate the efficacy, immunogenicity, and safety of an RSV and hMPV VLP vaccine compared with placebo in participants aged 60 ye… Pending

2024-513740-28-00 Respiratory Syncytial Virus and Human Metapneumovirus 5
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney D… Recruiting

2025-523123-22-00 Chronic Kidney Disease 5 2026-05-07
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes ( ENLIGHTEN-1). Recruiting

2025-523657-34-00 Obesity 5 2026-04-13
A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder (RENEW-ALC-1) Recruiting

2025-522313-38-00 Alcohol Use Disorder 5 2026-03-06
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) ( MOVE-Lp(a) ) Ended

2025-521067-13-00 Atherosclerotic Cardiovascular Disease (ASCVD) 5 2026-04-24
A study on the safety, and immunogenicity of a UTI vaccine in adults 18 through 64 years of age and clinical efficacy in females 18 through … Ended

2024-519319-32-00 Urinary Tract Infections 7 2025-08-27
An extension and crossover vaccination study on the immune response and safety of a vaccine against respiratory syncytial virus given to adu… Ended

2023-509762-38-00 Respiratory Syncytial Virus Infections 5 2024-08-01
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-OUTCOMES) Ended

2023-508630-34-00 Overweight 5 2024-05-28
A study on the immune response and safety of a vaccine against respiratory syncytial virus (RSV) when given alone and together with a vaccin… Ended

2023-510196-59-00 Respiratory Syncytial Virus Infections 5 2024-06-15
A Phase III, open-label, randomized, controlled, multi-country study to evaluate the immune response, safety, and reactogenicity of respirat… Ended

2022-501988-40-00 RSV-associated (subtypes A and B) disease in adults age 5 2023-08-17
A study to find and confirm the dose and assess the safety, reactogenicity and immune response of a vaccine against influenza in healthy you… Ended

2022-502308-66-00 Healthy volunteers (prevention of influenza infection) 7 2023-04-27